Category Genel

18 Feb

Ahmet Dirican: Is a New Agent Emerging for Metastatic Urothelial Carcinoma in the 2L+ Setting?

Ahmet Dirican: Is a New Agent Emerging for Metastatic Urothelial Carcinoma in the 2L+ Setting? Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X: “Is a new agent emerging for metastatic urothelial carcinoma in the 2L+ setting? Sacituzumab tirumotecan (sac-TMT) – a next-generation TROP2-directed ADC – shows promising activity after […]

18 Feb

Ahmet Dirican: Will AI Take Our Jobs?

Ahmet Dirican: Will AI Take Our Jobs? Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X: ” ‘Will AI take our jobs?’ After ESMO25, I couldn’t help but wonder… The truth is, AI isn’t here to replace us – it’s becoming the smart partner in clinical decisions. Oncology is […]

18 Feb

Ahmet Dirican: Liquid Biopsy – From Potential to Precision

Ahmet Dirican: Liquid Biopsy – From Potential to Precision Ahmet Dirican , Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on LinkedIn: “Liquid biopsy: from potential to precision Even at a ctDNA tumor fraction below 1%, liquid biopsy can detect key driver alterations – as shown in this case with EGFR L858R and […]

17 Jun

A New Era in Prostate Cancer Screening: Personalized Early Diagnosis with Genetic Risk Score (PRS)

A New Era in Prostate Cancer Screening: Personalized Early Diagnosis with Genetic Risk Score (PRS) 1. Why is Prostate Cancer Important? Approximately 1.5 million men are diagnosed with prostate cancer each year, and this disease is one of the most common types of cancer in men after skin cancer. When diagnosed at an early stage, […]